Neil W. Gibson - 11 Jun 2026 Form 4 Insider Report for Instil Bio, Inc. (TIL)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Jun 2026, 14:38:23 UTC
Prior SEC filing
02 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sandeep Laumas, M.D. Attorney-in-Fact for Neil W Gibson

Key filing fact

Neil W. Gibson filed Form 4 for Instil Bio, Inc. (TIL) on 12 Jun 2026.

Key facts

  • This page summarizes Neil W. Gibson's Form 4 filing for Instil Bio, Inc. (TIL).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 12 Jun 2026, 14:38.

Change

  • Previous filing in this sequence was filed on 02 Jun 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001555918 Primary reporting owner

Gibson Neil W

Relationship
Director
Address
C/O INSTIL BIO, INC., 3963 MAPLE AVENUE, SUITE 350, DALLAS
Signature
/s/ Sandeep Laumas, M.D. Attorney-in-Fact for Neil W Gibson
Signature date
12 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TIL transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
0
Change %
0%
Price
$0.000000*
Shares after
6,500
Date
11 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
6,500
Exercise price
$7.93
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option will vest in 12 substantially equal monthly installments commencing on July 11, 2026, subject to the Reporting Person's Continuous Service (as defined in the company's 2021 Equity Incentive Plan, the "Plan") through the vesting dates. Any portion of the option not vested on the date of the next annual stockholder meeting will vest in full, subject to the Reporting Person's Continuous Service through such date. The option will also vest in full in the event of the Reporting Person's death, Disability (as defined in the Plan) or upon a Change in Control (as defined in the Plan).

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .